• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: May 4-8, 2009

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Joshua Sharfstein, Acting Commissioner Food and Drugs5/5/09Baltimore, MDN/AGlen Flores, (University of Texas Southwestern Medical Center) Lisa Simpson, (Children’s Hospital  Medical Center,  University of  Cincinnati)Speech on “How Research Affects FDA Policy on Medical Products”  given at the Pediatric Academic Societies Annual Meeting
Joshua Sharfstein, Acting Commissioner Food and Drugs5/8/09College Park, MDN/AChisaraokwu N. Asomugha, Jill Barron, Irwin M. Birnbaum, Peggy Chen, Howard P. Forman, Katherine Goodrich, Luke O. Hansen, Lara W. Johnson, SreyRam Kuy, Adam B. Landman, Danil V. Makarov, Jerold R.Mande, Michael Phipps, Rao, Mitesh B., Joseph Ross, Erica S. Spatz, Kate V. Viola (Yale University School of Medicine)Meet and greet with Robert Wood Johnson clinical scholars
Joshua Sharfstein, Acting Commissioner Food and Drugs5/8/09Washington, DCRobert  Bronaugh, Patricia Hansen, Stanley Milstein, Donald Havery, John Gasper, Diego Rua, Patrick  McCarthy, Katz, Linda, Sandra Russell John Bailey (Personal Care Product Council), Linda Loretz (Safety and Regulatory Toxicology), Kathy Wille, (Johnson & Johnson Consumer & Personal Products Company Worldwide), Rio Tinto Minerals Meeting to discuss Talc Petition
Jesse Goodman, Chief Scientist and Acting Deputy Commissioner5/4/09-5/8/09N/AN/AN/ANo significant meetings
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer5/4/09-5/8/09N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs5/8/09National Harbor, MarylandN/AN/ASpeech: CHPA Regulatory & Scientific Conference
Randall Lutter, Deputy Commissioner for Policy5/4/09-5/8/09N/AN/AN/ANo significant meetings
Janet Woodcock, Director, Center for Drug Evaluation and Research5/4/09-5/8/09N/AN/AN/ANo significant meetings
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs5/4/09-5/8/09N/AN/AN/ANo significant meetings
Karen Midthun, Acting Director, Center for Biologics Evaluation and Research5/4/09-5/8/09N/AN/AN/ANo significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health5/4/09-5/8/09N/AN/AN/ANo significant meetings
Stephen Sundlof, Center for Food Safety and Applied Nutrition5/4/09-5/8/09N/AN/AN/ANo significant meetings
Bernadette Dunham, Director, Center for Veterinary Medicine5/4/09-5/8/09N/AN/AN/ANo significant meetings
William Slikker, Director, National Center for Toxicological Research5/4/09-5/8/09N/AN/AN/ANo significant meetings
Michael M. Landa, Acting Chief Counsel5/4/09-5/8/09N/AN/AN/ANo significant meetings